Acumen Pharmaceuticals (ABOS) Income Statement (2020 - 2026)
Income Statement report data from Jun 30, 2020 to Mar 31, 2026 for Acumen Pharmaceuticals (ABOS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||
Research And Development | 16M (-19.73%) | 21M (-6.55%) | 22M (-40.83%) | 37M (+46.93%) | 25M (-26.90%) | 35M (+26.86%) | 27M (+39.53%) | 20M (+56.87%) | 12M (-6.32%) | 13M (+18.87%) | 11M (+22.45%) | 9.13M (+4.82%) | 8.71M (-18.98%) | 11M (+29.36%) | 8.31M (+13.52%) | 7.32M (+22.20%) | 5.99M (+5.64%) | 5.67M (+215.00%) | 1.80M (-20.00%) | 2.25M (-12.79%) | 2.58M (-13.71%) | 2.99M (+54.92%) | 1.93M |
Selling General And Administrative | 4.67M (0.00%) | 4.67M (+2.64%) | 4.55M (-1.73%) | 4.63M (-9.22%) | 5.10M (+1.39%) | 5.03M (+0.20%) | 5.02M (+3.51%) | 4.85M (-9.01%) | 5.33M (+2.70%) | 5.19M (+6.79%) | 4.86M (+11.72%) | 4.35M (-1.58%) | 4.42M (+26.29%) | 3.50M (+14.38%) | 3.06M (-0.97%) | 3.09M (-4.04%) | 3.22M (+17.52%) | 2.74M (+28.64%) | 2.13M (+78.99%) | 1.19M (-2.46%) | 1.22M (+430.43%) | 230K (-11.54%) | 260K |
Operating Expenses | 21M (-16.07%) | 25M (-4.94%) | 27M (-36.50%) | 42M (+37.47%) | 30M (-23.31%) | 40M (+22.71%) | 32M (+32.36%) | 24M (+37.20%) | 18M (-3.89%) | 18M (+15.27%) | 16M (+18.99%) | 13M (+2.59%) | 13M (-7.79%) | 14M (+25.33%) | 11M (+9.22%) | 10M (+13.03%) | 9.21M (+9.51%) | 8.41M (+113.45%) | 3.94M (+14.53%) | 3.44M (-9.23%) | 3.79M (+17.70%) | 3.22M (+47.03%) | 2.19M |
Depreciation And Amortization | 10K (-75.00%) | 40K | - | - | 20K (-60.00%) | 50K | - | - | 20K (-60.00%) | 50K | - | - | 10K (-66.67%) | 30K | - | - | - | - | - | - | - | - | - |
Operating Income | |||||||||||||||||||||||
Operating Income | -21.15M (-16.07%) | -25.20M (-4.94%) | -26.51M (-36.50%) | -41.75M (+37.47%) | -30.37M (-23.31%) | -39.60M (+22.75%) | -32.26M (+32.32%) | -24.38M (+37.20%) | -17.77M (-3.89%) | -18.49M (+15.27%) | -16.04M (+18.99%) | -13.48M (+2.67%) | -13.13M (-7.86%) | -14.25M (+25.33%) | -11.37M (+9.22%) | -10.41M (+13.03%) | -9.21M (+9.51%) | -8.41M (+113.99%) | -3.93M (+14.24%) | -3.44M (-9.23%) | -3.79M (+52.21%) | -2.49M (+22.66%) | -2.03M |
Ebit | -21.15M (-16.07%) | -25.20M (-4.94%) | -26.51M (-36.50%) | -41.75M (+37.47%) | -30.37M (-23.31%) | -39.60M (+22.75%) | -32.26M (+32.32%) | -24.38M (+37.20%) | -17.77M (-3.89%) | -18.49M (+15.27%) | -16.04M (+18.99%) | -13.48M (+2.67%) | -13.13M (-7.86%) | -14.25M (+25.33%) | -11.37M (+9.22%) | -10.41M (+13.03%) | -9.21M (+9.51%) | -8.41M (+113.99%) | -3.93M (+14.24%) | -3.44M (-9.23%) | -3.79M (+52.21%) | -2.49M (+22.66%) | -2.03M |
EBITDA | -21.14M (-24.85%) | -28.13M (+10.84%) | -25.38M (-36.39%) | -39.90M (+31.47%) | -30.35M (-36.67%) | -47.92M (+66.74%) | -28.74M (+47.16%) | -19.53M (+9.97%) | -17.76M (-24.07%) | -23.39M (+80.48%) | -12.96M (+11.63%) | -11.61M (-11.51%) | -13.12M (-13.34%) | -15.14M (+41.36%) | -10.71M (+5.52%) | -10.15M (+10.33%) | -9.20M | 73M | -3.88M (-93.68%) | -61.36M (+127.26%) | -27.00M (+984.34%) | -2.49M (+22.66%) | -2.03M |
Other Income / Expenses | |||||||||||||||||||||||
Interest Income | 1.06M (-19.70%) | 1.32M (-19.51%) | 1.64M (-18.81%) | 2.02M (-18.22%) | 2.47M (-17.39%) | 2.99M (-14.57%) | 3.50M (-8.38%) | 3.82M (-4.74%) | 4.01M (-30.62%) | 5.78M (+85.26%) | 3.12M (+65.96%) | 1.88M | - | - | - | - | - | -40.00K | 40K | - | - | - | - |
Interest Expense | 1.07M (-1.83%) | 1.09M (+1.87%) | 1.07M (+1.90%) | 1.05M (+2.94%) | 1.02M (-1.92%) | 1.04M (+0.97%) | 1.03M (+3.00%) | 1.00M (0.00%) | 1.00M (+72.41%) | 580K | - | - | - | - | - | - | - | -20.00K | 20K | - | - | - | - |
Net Interest Income | 1.06M (-19.70%) | 1.32M (-19.51%) | 1.64M (-18.81%) | 2.02M (-18.22%) | 2.47M (-38.10%) | 3.99M (+14.00%) | 3.50M (-8.38%) | 3.82M (+26.91%) | 3.01M (-42.12%) | 5.20M (+66.67%) | 3.12M (+65.96%) | 1.88M | - | - | - | - | - | -20.00K | 10K | - | - | - | - |
Other Non Operating Income | -40.00K (-85.19%) | -270.00K (+285.71%) | -70.00K (-46.15%) | -130.00K (+116.67%) | -60.00K (-60.00%) | -150.00K | 30K | -70.00K (+40.00%) | -50.00K (-37.50%) | -80.00K (+100.00%) | -40.00K (+100.00%) | -20.00K | - | -10.00K | - | - | - | 50K (+150.00%) | 20K (0.00%) | 20K (+100.00%) | 10K | - | - |
Net Income | |||||||||||||||||||||||
Net Income From Continuing Operations | -20.74M (-17.50%) | -25.14M (-4.95%) | -26.45M (-35.41%) | -40.95M (+42.19%) | -28.80M (-22.48%) | -37.15M (+24.83%) | -29.76M (+44.89%) | -20.54M (+38.13%) | -14.87M (-9.88%) | -16.50M (+27.31%) | -12.96M (+11.63%) | -11.61M (+2.65%) | -11.31M (-12.12%) | -12.87M (+20.17%) | -10.71M (+5.52%) | -10.15M (+11.17%) | -9.13M (+9.34%) | -8.35M (+114.10%) | -3.90M (-93.64%) | -61.36M (+127.26%) | -27.00M (+984.34%) | -2.49M (+22.66%) | -2.03M |
Net Income | -20.74M (-17.50%) | -25.14M (-4.95%) | -26.45M (-35.41%) | -40.95M (+42.19%) | -28.80M (-22.48%) | -37.15M (+24.83%) | -29.76M (+44.89%) | -20.54M (+38.13%) | -14.87M (-9.88%) | -16.50M (+27.31%) | -12.96M (+11.63%) | -11.61M (+2.65%) | -11.31M (-12.12%) | -12.87M (+20.17%) | -10.71M (+5.52%) | -10.15M (+11.17%) | -9.13M (+9.34%) | -8.35M (+114.10%) | -3.90M (-93.64%) | -61.36M (+127.26%) | -27.00M (+984.34%) | -2.49M (+22.66%) | -2.03M |
Comprehensive Income Net Of Tax | -20.80M (-82.84%) | -121.20M (+359.79%) | -26.36M (-35.61%) | -40.94M (+42.50%) | -28.73M (-72.02%) | -102.69M (+253.13%) | -29.08M (+41.44%) | -20.56M (+34.12%) | -15.33M (-70.12%) | -51.31M (+300.23%) | -12.82M (+9.29%) | -11.73M (+5.87%) | -11.08M (-74.46%) | -43.38M (+305.04%) | -10.71M (+3.98%) | -10.30M (+6.08%) | -9.71M (-90.37%) | -100.84M (+2465.90%) | -3.93M | - | - | -2.49M | - |